89 related articles for article (PubMed ID: 15478649)
1. [Cancer stem cells in pediatric brain tumors].
Nakano I; Hemmati HD; Kornblum HI
No Shinkei Geka; 2004 Aug; 32(8):827-34. PubMed ID: 15478649
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor stem cells.
Nakano I; Kornblum HI
Pediatr Res; 2006 Apr; 59(4 Pt 2):54R-8R. PubMed ID: 16549549
[TBL] [Abstract][Full Text] [Related]
3. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
4. Translational research strategies applied to glioma therapeutics.
Berger MS; Keles GE
Clin Neurosurg; 2004; 51():203-6. PubMed ID: 15571146
[No Abstract] [Full Text] [Related]
5. Cancer stem cells in nervous system tumors.
Singh SK; Clarke ID; Hide T; Dirks PB
Oncogene; 2004 Sep; 23(43):7267-73. PubMed ID: 15378086
[TBL] [Abstract][Full Text] [Related]
6. Glioma-initiating cells and molecular pathology: implications for therapy.
Natsume A; Kinjo S; Yuki K; Kato T; Ohno M; Motomura K; Iwami K; Wakabayashi T
Brain Tumor Pathol; 2011 Feb; 28(1):1-12. PubMed ID: 21274750
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
8. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
9. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
[TBL] [Abstract][Full Text] [Related]
10. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.
Lilja JF; Wu D; Reynolds RK; Lin J
Anticancer Res; 2001; 21(3B):1969-74. PubMed ID: 11497285
[TBL] [Abstract][Full Text] [Related]
11. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
12. Cancerous stem cells can arise from pediatric brain tumors.
Hemmati HD; Nakano I; Lazareff JA; Masterman-Smith M; Geschwind DH; Bronner-Fraser M; Kornblum HI
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15178-83. PubMed ID: 14645703
[TBL] [Abstract][Full Text] [Related]
13. Methods for analysis of brain tumor stem cell and neural stem cell self-renewal.
Nakano I; Kornblum HI
Methods Mol Biol; 2009; 568():37-56. PubMed ID: 19582420
[TBL] [Abstract][Full Text] [Related]
14. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
15. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
[TBL] [Abstract][Full Text] [Related]
16. Loss of PTEN facilitates HIF-1-mediated gene expression.
Zundel W; Schindler C; Haas-Kogan D; Koong A; Kaper F; Chen E; Gottschalk AR; Ryan HE; Johnson RS; Jefferson AB; Stokoe D; Giaccia AJ
Genes Dev; 2000 Feb; 14(4):391-6. PubMed ID: 10691731
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Ermoian RP; Furniss CS; Lamborn KR; Basila D; Berger MS; Gottschalk AR; Nicholas MK; Stokoe D; Haas-Kogan DA
Clin Cancer Res; 2002 May; 8(5):1100-6. PubMed ID: 12006525
[TBL] [Abstract][Full Text] [Related]
18. Stem cells. PTEN--coupling tumor suppression to stem cells?
Penninger JM; Woodgett J
Science; 2001 Dec; 294(5549):2116-8. PubMed ID: 11739945
[No Abstract] [Full Text] [Related]
19. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
Ohigashi T; Mizuno R; Nakashima J; Marumo K; Murai M
Prostate; 2005 Jan; 62(1):61-8. PubMed ID: 15389810
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
